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Objectives: To investigate (i) the intra-rater, inter-rater and 
test-retest reliability of sideways walk test times and counts 
in individuals with stroke; (ii) their correlations with stroke-
specific measures of impairment; (iii) the cut-off sideways 
walk test times and counts between stroke survivors and 
healthy controls; and (iv) the minimum detectable changes 
in the sideways walk test times and counts. 
Design: Cross-sectional study.
Setting: University-based rehabilitation centre.
Subjects: Twenty-nine older adults with stroke and 32 
healthy controls.
Methods: The sideways walk test was conducted together 
with Fugl-Meyer motor assessments of the lower extremi-
ties, lower limb muscle strength tests, the Five-Times-Sit-
To-Stand test, Berg Balance Scale, Timed Up-and-Go test, 
and Activity-based Confidence and Community Integration 
Measure questionnaires. 
Results: The sideways walk test times and counts demon-
strated good to excellent intra-rater, inter-rater, and test-
retest reliabilities. The sideways walk test times and counts 
were significantly correlated with motor control and ankle 
dorsiflexor and plantarflexor strength of the affected leg, 
balance performance and functional mobility. The cut-off 
sideways walk test time and count that best discriminated 
between individuals with stroke and controls were 10.74 s 
and 8.83 steps, respectively. The minimal detectable change 
in the sideways walk test time in that situation was 1.85 s, 
and the count minimum detectable change was 1.12 steps.
Conclusion: The sideways walk test is a reliable and easy-to-
administer clinical test for assessing sideways walking abil-
ity of individuals with chronic stroke. 
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INTRODUCTION
Moving in narrow or otherwise restricted spaces is common 
in cities, where the home and even public areas are often 
small and crowded. An ability to walk sideways is an essential 
daily living skill in such places, needed to manoeuvre inside 
the kitchen or getting over obstacles (1). Being able to walk 
sideways steadily also facilitates people’s participation in 
the community. They can take public transport with greater 
confidence and pass through crowded corridors. This ability 
is also important to in order to participate in various sports, 
such as football (2).
Individuals with stroke typically have neurological impair-
ments, muscle weakness and sensation deficits, contributing to 
impaired performance in walking and daily activities (3, 4). As 
the metabolic cost of walking sideways is 3 times greater than 
that of walking forwards (5), after stroke individuals use more 
energy in postural control and walking than healthy persons 
performing the same task (6). Thus, their sideways walking 
ability may serve as an indicator of their general functional 
capability in walking sideways and their participation in daily 
activities at home and in the community (7). Improving side-
ways walking is thus a useful goal in stroke rehabilitation. 
The sideways walk test (SWT) was firstly developed to 
evaluate dynamic walking balance in sideways walking of 
individuals with Parkinson’s disease (PD) (8). Individuals are 
instructed to walk sideways at their self-selected pace towards 
the right and left for 5 m. The completion time and the step 
count are recorded. The SWT has demonstrated excellent 
inter-rater reliability, with intra-class correlation coefficients 
(ICCs) ranging from 0.87 to 0.99 for individuals with PD (8). 
Despite the potential use of the SWT in stroke rehabilitation, 
the intra-rater, inter-rater and test-retest reliabilities and the 
construct validity of the SWT time and count for individuals 
with stroke have not yet been established. 
The objectives of this study were, therefore, to assess: (i) 
the intra-rater, inter-rater, and test-retest reliabilities of the 
SWT times and counts generated by individuals with stroke; 
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(ii) the construct validity of SWT times and counts for char-
acterizing stroke-specific impairments; (iii) the cut-off time 
and count that most effectively discriminate individuals with 
stroke from healthy controls; and (iv) the minimal detectable 
changes (MDCs) of the SWT times and counts of individuals 
with stroke. 
METHODS
This study was a cross-sectional clinical trial. A previous study has 
demonstrated excellent intra-rater and inter-rater reliabilities of the 
SWT for individuals with PD, yielding ICCs ranging from 0.87 to 
0.99 (8). Assuming the ICC for individuals with stroke is 0.90, to 
detect a statistically significant difference at a significance level of 
0.05, a power analysis shows that a sample size of 26 subjects would 
be required to achieve a power of 81% (9).
Twenty-nine individuals with stroke aged over 55 years were re-
cruited from a local self-help group. This age threshold was chosen 
because the incidence of stroke approximately doubles each decade 
after the age of 55 years (10). Subjects were included if they were: 
(i) at least 12 months post-stroke; (ii) medically stable; (iii) able to 
walk at least 10 m independently with or without using any assistive 
device; (iv) able to score 7 or more on the Abbreviated Mental Test; 
and (v) able to understand and follow simple instructions. Subjects 
were excluded if they had any neurological disorder or other comorbid 
disabilities that would hinder proper assessment. 
Thirty-two healthy controls aged over 55 years were recruited from 
the local community using poster advertising. Control candidates were 
excluded if they had any neurological or musculoskeletal problem 
affecting their mobility. 
The study was approved by the ethics committee of the Hong Kong 
Polytechnic University and conducted according to the guidelines of 
the Declaration of Helsinki. Before the start of study, all of the eligible 
participants were informed about the objectives and procedures of the 
study, and written consent was obtained before the start of the study. 
Outcome measures
Sideways walk test (SWT). The SWT was performed as described 
in a previous study (8). A 5-m walkway, with an extra of 2 m for 
deceleration, was marked out with coloured tape (8). Individuals 
were instructed to stand with the inner sides of their feet touching the 
starting line, and then walk sideways along the 5 m walkway at the 
self-selected speed. When the examiner announced “start”, the subject 
started to abduct the leading leg, followed by adduction of the trailing 
leg with the inner sides of feet touching each other. Both the time and 
the step count were recorded. Each subject performed 1 practice trial 
and then 3 timed trials toward both the affected and unaffected sides, 
in a randomized manner.
Fugl–Meyer Motor Assessment for the lower extremities (FMA-LE). 
The FMA-LE quantifies motor impairment of the lower extremities 
after stroke, including reflexes, movement synergies and coordina-
tion (15). It has demonstrated high inter-rater reliability (ICCs range 
0.83–0.95) (9). The FMA-LE consists of 17 items, with a maximum 
score of 34. 
Lower limb muscle strength. The isometric strength of the subjects’ hip 
abductors, ankle dorsiflexors and ankle plantarflexors were measured 
bilaterally using a Nicholas hand-held dynamometer (model 01160; 
Lafayette Instrument Company, Lafayette, IN, USA). Such hand-
held dynamometer measurements have been shown to be objective 
and precise, with good to excellent intra-rater reliability (ICCs range 
0.76–0.89) reported for individuals with stroke (12). The “make” test 
was used in this study (13, 14). One practice trial and 3 trials were 
performed for each muscle group, and each muscle contraction was 
held for 3–5 s, with a rest period of 2 min between trials. 
A Cybex 6000 dynamometer (Cybex International Inc., Medway, 
MA, USA) was employed in measuring isokinetic contractile force 
generated by the knee flexors and extensors at 90°/s. The mean peak 
torque from 5 contractions was recorded (15).
Five-Times-Sit-To-Stand (FTSTS) test. The FTSTS test was initially 
designed to quantify frailty and disability and predict mortality among 
older adults (16, 17). It has shown excellent reliability in people with 
stroke, with ICCs in the range 0.97–1.00 (18). Subjects were required 
to complete 5 repetitions of a sit-to-stand manoeuvre as quickly as 
possible with their arms crossed on their chests. One practice trial and 
3 timed trials were performed. 
Berg Balance Scale (BBS). The BBS is a well-known clinical test of 
an individual’s ability to maintain balance (19). Excellent reliability 
(ICCs range 0.98–0.99) has been demonstrated among individuals 
with stroke (20). Subjects were tested on 14 tasks required in everyday 
living, and the quality and speed of their task completion were rated 
using a 5-point (0–4) scale, adding up to a maximum score of 56 (19).
Timed up and go (TUG) test. The TUG test was devised to quantify the 
functional mobility of frail elderly persons (21). The TUG test times 
delivers excellent test-retest reliability (ICCs > 0.95) for individuals 
after stroke (22). Subjects were instructed to stand up from a chair, walk 
3 m forwards, turn in the direction of their choice, return to the chair 
and sit down. Each subject performed 1 practice trial and 3 timed trials.
Activities-specific Balance Confidence Scale (ABC-C). The ABC-C 
instrument is a self-administered questionnaire designed to assess 
subjective perceptions of balance confidence in performing various 
indoor and outdoor activities (23). The questionnaire is composed of 
10 items, and the score range is from 0 to 100. A Chinese version of 
the questionnaire demonstrated very good inter-rater and test-retest 
reliabilities, with ICCs of 0.99 and 0.85, respectively (24). 
Community Integration Measure – Cantonese version (CIM-C). The 
CIM-C instrument is a questionnaire assessing community integra-
tion, designed for individuals with stroke living in Hong Kong (25). 
The instrument has 10 items, with each item soliciting a rating on a 
5-point scale, giving the total score from 10 to 50. The CIM-C has 
demonstrated high internal consistency (Cronbrach’s alpha = 0.84) 
with good test-retest reliability (an ICC of 0.84, significant at the 95% 
level of confidence) (25). 
Testing procedures. The SWT was conducted on 2 separate days 7 
days apart, to establish its test-retest reliability (Fig. 1). The times and 
counts were recorded simultaneously by 2 independent, trained raters 
in order to establish its inter-rater reliability, while the records of each 
over 3 trials were compared in order to quantify intra-rater reliability.
In addition to SWT, subjects with stroke completed FMA-LE, 
lower limb muscle strength measurement, FTSTS, BBS, TUG tests, 
Fig. 1. Testing procedures for examining intra-rater, inter-rater and test-
retest reliabilities of the sideways walk test.
 
 
 
 
 
 
 
 
 
 
Sideways walk test
Intra-rater reliability
Results collected from 
Rater 1 and 2 (3 trials 
were collected, 1 min 
rest between each 
trial)
Inter-rater reliability
Same individual's 
result collected by 
Rater 1 and 2 
simultaneously
Test-retest reliability
Tests conducted twice 
within 7–10 days
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ABC and CIM-C questionnaires in a random order to establish the 
correlations between SWT and other outcome measurements. At least 
2-min rest was given between measurements to minimize the effect 
of fatigue. The mean values of the replicate trials were computed for 
data analysis. Both affected and unaffected SWT times and counts had 
been expected to have negative correlations with FMA-LE, muscle 
strength measurements and BBS scores. On the other hand, the SWT 
times and counts had been expected to have negative correlations with 
FTSTS, TUG times, ABC and CIM scores.
The healthy controls completed the SWT in one session only. Their 
data were collected to identify the differences in SWT times and counts 
between individuals with stroke and healthy controls.
Statistical analysis 
Data analysis was conducted using version 22 of the SPSS software 
(IBM Corp.). 
Descriptive statistics were used to summarize demographic informa-
tion. The Shapiro-Wilk test and Levene’s test was used to check the 
normality of the data and the homogeneity of variances, respectively. 
For computing between-group differences, independent t-tests and the 
Mann-Whitney U test were used for the parametric and non-parametric 
data, respectively (26). 
ICCs were computed to measure intra-rater reliability (ICC3,1), 
inter-rater reliability (ICC2,2) and test-retest reliability (ICC3,2) (26). 
Correlations between SWT performance and other outcome measure-
ments were quantified using Pearson correlation coefficients if the 
data were normally distributed and homogeneous; otherwise Spear-
man’s rho was used. The ρ value indicating significance was adjusted 
to 0.003 (0.05/16) after Bonferroni adjustment for all 16 outcome 
measures (27), as FMA-LE, affected lower limb muscle strength 
measurement, FTSTS, BBS, TUG tests, ABC and CIM-C were our 
primary outcome measures.
The MDCs were calculated as (26):
MDC = 1.96 × SEM × √2.
where SEM is the standard error of measurement of the SWT times 
or counts, calculated as
SEM = S√(1- r).
where S is the standard deviation of the SWT times or counts, and 
r is the reliability coefficient.
Receiver operating characteristic curves were plotted to determine 
the cut-off SWT times and counts best distinguishing individuals with 
stroke from healthy controls, with a trade-off between sensitivity and 
1 minus specificity performed by Youden’s index (27). 
RESULTS
Twenty-nine individuals with stroke were recruited (18 men, 
11 women; mean age and standard deviation (SD), 60 years (SD 
6.3); mean and SD years since stroke 9.2 years (SD 4.5)) (Table 
I). There were 32 healthy controls in this study (10 men, 22 
women; mean age 61.8 years (SD 4.6)) (Table I).
The mean SWT times and counts of individuals with stroke 
and healthy controls are shown in Table II. In general, individu-
als with stroke took significantly longer times and more steps 
to complete the SWT than the healthy controls when moving 
toward both the affected and the unaffected side (Table II). 
Good to excellent intra-rater, inter-rater and test-retest reli-
abilities were found for the SWT times and counts, with ICCs 
Table I. Demographics of the individuals with stroke and the healthy 
controls
Characteristics
Stroke 
(n =  29)
Healthy 
(n =  32) p-value
Age, years, mean (SD) 60.0 (6.3) 61.8 (4.6) 0.265
Sex, male/female, n 18/11 10/22 0.016*
Height, cm, mean (SD) 161.3 (7.3) 157.3 (6.5) 0.025*
Weight, kg, mean (SD) 66.2 (12.4) 57.8 (7.4) 0.008*
Body mass index, kg/m2, mean (SD) 25.2 (3.2) 23.3 (2.5) 0.011*
Years since stroke, mean (SD) 9.2 (4.5) NA NA
Affected side, left/ right, n 9/20 NA NA
Abbreviated Mental Test, mean (SD) 9.4 (0.8) NA NA
*Indicates a significant difference at the p ≤ 0.05 level of confidence.
NA: not applicable. SD: standard deviation.
Table II. Mean sideways walk test (SWT) times and counts and stroke-specific impairment outcome measures for individuals with stroke and healthy 
controls
Parameters
Individuals with stroke (n = 29) Healthy
(n = 32)
Mean (SD) 
p (compared with healthy 
controls)
p (affected side compared 
with unaffected)
Affected 
Mean (SD) 
Unaffected
Mean (SD) Affected Unaffected
Time (s) 16.2 (6.7) 15.2 (5.9) 9.00 (2.5) < 0.001* < 0.001* 0.549
Step count 11.6 (3.8) 10.9 (3.3) 7.5 (1.3) < 0.001* < 0.001* 0.438
FMA-LE score 24.06 (6.17)
Muscle strength
Hip abductors (N) 14.15 (4.36) 16.37 (3.81) 0.001*
Knee flexors (Nm) 10.00 (7.73) 23.06 (9.97) 0.001*
Knee extensors (Nm) 27.81 (17.91) 47.28 (21.29) < 0.0001*
Ankle dorsiflexors (N) 9.69 (5.44) 15.27 (3.23) < 0.0001*
Ankle plantarflexors (N) 14.16 (5.49) 18.78 (4.33) < 0.0001*
FTSTS (s) 18.55 (9.28)
BBS score 48.91 (4.16)
TUG (s) 15.34 (5.59)
ABC-C score 78.55 (15.45)
CIM-C score 46.06 (3.68)
Mean values were calculated from all the observations, including those from rater 1 and rater 2 on day 1. 
*Indicates a significant difference at the p ≤ 0.01 level of confidence.
SD: standard deviation; FMA-LE: Fugl–Meyer Motor Assessment for the lower extremities; FTSTS: Five-Times-Sit-To-Stand test; BBS: Berg Balance 
Scale; TUG: Timed up and go test; ABC-C: Activities-specific Balance Confidence Scale; CIM-C: Community Integration Measure-Cantonese version. 
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Table IV. Inter-rater reliability of the sideways walk test times and counts of individuals with stroke
Leading limb
Day 1 Day 2
Time (s)
ICC3,1 (95% CI)
Count
ICC3,1 (95% CI)
Time (s)
ICC3,1 (95% CI)
Count
ICC3,1 (95% CI)
Affected side 0.994 (0.990–0.997) 0.992 (0.986–0.996) 0.992 (0.987–0.996) 0.993 (0.988–0.996)
Unaffected side 0.989 (0.981–0.994) 0.987 (0.979–0.993) 0.987 (0.978–0.993) 0.974 (0.957–0.987)
95% CI: 95% confidence interval.
Fig. 2. Receiver operating characteristic (ROC) curves for the sideways walk test (SWT) times and counts when leading with the leg on the affected 
and unaffected sides. (A) ROC curve for unaffected SWT time (area under the curve (AUC) = 0.869; sensitivity, 81%; specificity, 81%; p < 0.001). (B) 
ROC curve for unaffected SWT count (AUC = 0.887; sensitivity, 83%; specificity, 84%; p < 0.001). (C) ROC curve for affected SWT time (AUC= 0 .880; 
sensitivity, 86%; specificity, 88%; p < 0.001). (D) ROC curve for affected SWT count (AUC = 0.864; sensitivity, 83%; specificity, 81%; p < 0.001).
(A)
 
 
(B)
 
 
(C)
 
 
(D)
 
 !
Table III. Intra-rater reliability of the sideways walk test times and counts of individuals with stroke
Leading limb/Rater
Day 1 Day 2
Time (s)
ICC3,1 (95% CI)
Count
ICC3,1 (95% CI)
Time (s)
ICC3,1 (95% CI)
Count
ICC3,1 (95% CI)
Affected side
Rater 1 0.970 (0.945–0.985) 0.958 (0.924–0.978) 0.956 (0.920–0.977) 0.968 (0.942–0.984)
Rater 2 0.962 (0.931–0.981) 0.967 (0.939–0.983) 0.957 (0.922–0.978) 0.962 (0.931–0.981)
Unaffected side
Rater 1 0.924 (0.866–0.961) 0.938 (0.889–0.968) 0.915 (0.849–0.956) 0.922 (0.862–0.960)
Rater 2 0.939 (0.892–0.969) 0.959 (0.925–0.979) 0.926 (0.869–0.962) 0.866 (0.769–0.930)
95% CI: 95% confidence interval.
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ranging from 0.866 to 0.970 for intra-rater reliability (Table 
III), 0.974 to 0.994 for inter-rater reliability (Table IV), and 
0.974 to 0.990 for test-retest reliability (Table V).
The MDCs of the SWT times were 1.85 s on the affected 
side and 2.13 s on the unaffected side, respectively. For the 
counts the corresponding MDCs were 1.12 and 1.48 steps, 
respectively. The best cut-off times for distinguishing between 
stroke and healthy subjects were 10.74 s travelling toward the 
affected side, and 10.19 s travelling toward the unaffected side 
(p ≤ 0.001).. For the step counts the corresponding cut-offs were 
8.83 and 8.17 steps (p ≤ 0.001). Details of the area under the 
curve (AUC) are shown in Fig. 2.
The SWT times on both the affected and unaffected sides 
correlated significantly with FMA-LE scores, FTSTS times, 
BBS scores and TUG times (Table VI) (Figs 3 and 4). Ankle 
dorsiflexor and plantarflexor strength on the affected side cor-
related significantly with the SWT times and counts in both 
directions (Table VI, Figs 3 and 4).
DISCUSSION
This is the first published study to investigate intra-rater, inter-
rater and test-retest reliabilities and correlation SWT times and 
counts between stroke-specific measures of impairment. It was 
also the first to determine the cut-off times and counts best 
discriminating individuals with stroke from healthy controls.
Reliability of the sideways walk test 
All SWT times and counts demonstrated good to excellent 
intra-rater, inter-rater and test-retest reliabilities. This probably 
resulted from the standardized instructions and set-up, and the 
well-trained raters who strictly followed the procedures. The 2 
min resting time between trials seems to have been sufficient 
to minimize fatigue, also perhaps contributing to the satisfac-
tory intra-rater reliability. In addition, the excellent test-retest 
reliabilities imply that 7 days was sufficiently long to minimize 
learning effects, yet short enough to avoid significant actual 
change in performance. 
Performance of sideways walk test
As expected, the healthy controls recorded shorter SWT times 
and fewer SWT counts than the individuals with stroke. The 
substantial difference SWT times and counts between the 2 
groups is presumably due to stroke-specific impairments, such 
as lower limb control and poor balance (28). Stroke survivors 
often display insufficient recruitment and decreased firing 
frequency of muscle motor units (29), localized adaption of 
paretic muscle fibres (30), and decreased voluntary activa-
tion (30). 
Table V. Test-retest reliability of the sideways walk test times and counts 
of individuals with stroke
Leading limb/Rater
Time (s)
ICC3,1 (95% CI)
 Count
ICC3,1 (95% CI)
Affected side
Rater 1 0.989 (0.981–0.994) 0.988 (0.979–0.993)
Rater 2 0.990 (0.982–0.995) 0.989 (0.982–0.994)
Unaffected side
Rater 1 0.981 (0.968–0.990) 0.974 (0.955–0.986)
Rater 2 0.983 (0.971–0.991) 0.975 (0.957–0.987)
95% CI: 95% confidence interval; ICC: intraclass correlation coefficient.
Table VI. Correlations relating the sideways walk test times and counts with indicators of stroke-specific impairment
Leading limb
Affected Unaffected
Time
Spearman’s rho (ρ)
Count
Spearman’s rho (ρ)
Time
Spearman’s rho (ρ)
 Count
Spearman’s rho (ρ)
FMA-LE –0.742* (p ≤ 0.0001) –0.667* (p ≤ 0.0001) –0.660* (p ≤ 0.0001) –0.662* (p ≤ 0.0001)
Muscle strength of lower limbs
Affected side strength
Hip abductor (N) –0.489 (p = 0.007) –0.500 (p = 0.006) –0.513 (p = 0.004) –0.419 (p = 0.024)
Knee flexor (Nm) –0.510 (p = 0.005) –0.456 (p = 0.013) –0.499 (p = 0.006) –0.455 (p = 0.013)
Knee extensor (Nm) –0.493 (p = 0.007) –0.418 (p = 0.024) –0.480 (p = 0.008) –0.458 (p = 0.013)
Ankle dorsiflexor (N) –0.586* (p = 0.001) –0.639* (p < 0.0001) –0.561* (p = 0.002) –0.446 (p = 0.015)
Ankle plantarflexor (N) –0.730* (p < 0.0001) –0.636* (p < 0.0001) –0.689* (p = 0.000) –0.587* (p = 0.001)
Unaffected side strength
Hip abductor (N) –0.385 (p = 0.039) –0.484 (p = 0.008) –0.409 (p = 0.027) –0.368 (p = 0.050)
Knee flexor (Nm) –0.099 (p = 0.609) –0.144 (p = 0.457) 0.003 (p = 0.989) –0.125 (p = 0.520)
Knee extensor (Nm) –0.110 (p = 0.569) –0.166 (p = 0.390) –0.036 (p = 0.853) –0.183 (p = 0.341)
Ankle dorsiflexor (N) –0.328 (p = 0.083) –0.399 (p = 0.032) –0.343 (p = 0.068) –0.358 (p = 0.057)
Ankle plantarflexor (N) –0.130 (p = 0.502) –0.065 (p = 0.738) –0.180 (p = 0.351) –0.089 (p = 0.646)
FTSTS (s) 0.568* (p ≤ 0.001) 0.597* (p ≤ 0.001) 0.591* (p ≤ 0.001) 0.621* (p ≤ 0.001)
BBS –0.617*(p ≤ 0.0001) –0.617* (p ≤ 0.0001) –0.544* (p = 0.002) –0.659* (p ≤ 0.000)
TUG test (s) 0.673* (p < 0.0001) 0.727* (p < 0.0001) 0.662* (p < 0.0001) 0.615* (p < 0.0001)
ABC-C –0.297 (p = 0.118) –0.331 (p = 0.080) –0.341 (p = 0.070) –0.471 (p = 0.010)
CIM-C –0.158 (p = 0.414) –0.026 (p = 0.894) –0.087 (p = 0.665) –0.056 (p = 0.771)
*Significant correlation after Bonferroni adjustment at a p-value of 0.05/16 (p ≤ 0.003).
FMA-LE: Fugl-Meyer Motor Assessment for the lower extremities; FTSTS: Five-Times-Sit-To-Stand test; BBS: Berg Balance Scale; TUG: Timed 
up and go test; ABC-C: Activities-specific Balance Confidence Scale; CIM-C: Community Integration Measure-Cantonese version.
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The MDCs of the affected and unaffected SWT times were 1.85 
s and 2.13 s, while those of the affected and unaffected SWT counts 
were 1.12 and 1.48 steps, respectively. Such values would indicate 
actual changes in capability rather than chance deviations. The 
mean difference in SWT times between individuals with stroke 
and the healthy controls was 7.2 s (affected) or 6.2 s (unaffected), 
while the differences in mean step count were 4.1 steps (affected) 
and 3.4 steps (unaffected). Since those differences were greater 
than the corresponding MDCs, the longer SWT times and the 
additional SWT counts represent true differences in performance.
Fig. 3. Relationship between affected sideways walk test (SWT) times with: (A) Fugl-Meyer Assessment Lower Extremity scores (r = –0.742, p ≤ 0.0001); 
(B) affected ankle dorsiflexor strength (r = –0.586, p = 0.001); (C) affected ankle plantarflexor strength (r = –0.73, p ≤ 0.0001); (D) five time sit-to-stand 
test (r = 0.568, p ≤ 0.001); (E) Berg Balance Scale scores (r = –0.617, p ≤ 0.0001); (F) timed up and go times (r = 0.673, p ≤ 0.0001). 
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It is interesting to note that the SWT times of these individu-
als with stroke (affected: 16.2s and unaffected: 15.2s) were 
longer than those for typical PD sufferers (9.3 s under medica-
tion or 11.9 s off medication) (8). This agrees with the results 
of a previous study, that individuals with PD demonstrated 
faster walking speed than those with stroke in a 10-m-walk 
test (30). In terms of step count, there was no significant differ-
ence from the counts of individuals with PD after medication 
Fig. 4. Relationship between unaffected sideways walk test (SWT) times with: (A) Fugl-Meyer Assessment Lower Extremity scores (r = –0.66, 
p ≤ 0.0001); (B) affected ankle dorsiflexor strength (r = –0.561, p = 0.002); (C) affected ankle plantarflexor strength (r = –0.689, p ≤ 0.0001); (D) 5 time 
sit-to-stand test times (r = 0.591, p ≤ 0.001); (E) Berg Balance Scale scores (r = –0.544, p = 0.002); (F) timed up and go times (r = 0.6621, p ≤ 0.0001). 
 
A D 
 
 
 
 
 
 
 
 
 
 
 
 
B E 
 
 
 
 
 
 
 
 
 
 
 
 
C
 
F
 
 
 
 
 
 
 
 
 
 
 
 
 
J Rehabil Med 48
664 S. S. M. Ng et al.
(10.8 steps). This too agrees with the results of a previous 
study, which found that the stride lengths of individuals with 
PD and stroke are similar (31). Individuals with PD who are 
off medication require more steps (13.1 steps) to complete the 
SWT. This is probably related to bradykinesia (32). The dif-
ferences in demographics among different studies, including 
ethnicity, age and types and severity of the disease, could also 
be variants contributing to these discrepancies. 
Furthermore, those individuals with stroke require more count 
to complete the SWT. This could be due to stroke-specific im-
pairment, including poor lower limb control and poor balance 
ability (28). In order to maintain dynamic balance and increase 
static stability while performing the SWT, those individuals with 
stroke might take shorter steps, resulting in a higher SWT count. 
Correlations of the sideways walk test times and counts with 
other measures
The affected and unaffected SWT times and counts demon-
strated significant negative correlation with FMA-LE scores 
(r = –0.742 to –0.660). The FMA-LE was designed to evaluate 
reflexes, isolated control and coordination of the lower limbs, 
all of which should be related to performance in the SWT in 
terms of both time and step count. Moreover, the FMA-LE 
scores have been shown to correlate with the (forwards) walk-
ing velocity and endurance of individuals with stroke, which 
additionally supports the correlation of the SWT times with 
the FMA-LE scores (33, 34). 
The SWT performance was also significantly correlated with 
the strengths of the ankle dorsiflexors and plantarflexors on the 
affected side (r = –0.730 to –0.561). During sideways walking, 
the foot swing is initiated by pushing off through ankle plan-
tarflexion and cleared off the ground with ankle dorsiflexion, 
while the supporting leg uses the ankle muscles for stabiliza-
tion (35). Indeed, the strength of the ankle plantarflexors on 
the affected side showed the strongest correlation among all 
the muscle strength results and detailed inverse dynamics is 
warranted to reveal the role of push-off power in the leading 
and trailing legs correspondingly.
The affected and unaffected SWT times and counts signifi-
cantly correlated with FTSTS completion times (r = 0.568 to 
0.621). FTSTS completion times measures functional lower 
limb strength, which is well known to be correlated with gait 
velocity after stroke (35, 36). 
The SWT times and counts significantly correlated with the 
BBS scores (r = –0.659 to –0.544). Although the BBS does not 
include sideways walking, the challenge to balance is similar 
in some of the BBS tasks, such as alternate stepping, which 
requires alternating weight shifting and single leg standing 
with changes in the base of support. 
Both the SWT times and counts showed significant correla-
tion with TUG time (r = 0.615 to 0.727). The rising from sitting 
and sitting from standing movements are similar to movements 
in the FTSTS test, while the turning movement coincides 
with the turning task in the BBS. It is therefore reasonable to 
expect significant correlation between performance of SWT 
and TUG times.
It is surprising to note that the SWT times and counts did 
not show any significant correlation with ABC-C and CIM-
C scores, despite the fact that ABC-C results are known to 
correlate with BBS scores (37). Such discrepancy could be 
explained by the fact that the ABC-C was designed to measure 
self-perceptions of efficacy in daily living tasks calling for 
balance, while CIM-C evaluates subjective community par-
ticipation and integration. This was different from the physical 
performance measured by the SWT. In addition, the current 
study was conducted in a secure and controlled environment, 
which is different from the real-life environment of the ABC-
C and CIM-C.
The SWT cut-off times and counts could discriminate healthy 
controls from those with chronic stroke, with the AUC ranging 
from 0.864 to 0.887. The best cut-off times and counts were 
10.74 s and 8.83 steps when leading with the affected leg, and 
10.19 s and 8.17 steps with the unaffected leg leading. The AUC 
of 86.4–88.7% signifies the probability of identifying someone 
with impaired functional mobility using SWT times or counts.
Limitations 
All of these results were generated by Chinese individuals 
aged over 55 years who met the inclusion criteria. The results 
may not, therefore, automatically generalize to all ages and 
ethnicities. Secondly, this study only measured SWT times and 
counts, not the quality of movement during sideways peram-
bulation. Further research investigating gait and movement 
patterns seems justified to develop ways of quantifying the 
movement quality during sideways walking. Future work might 
also examine other possible neuromuscular factors, such as 
coordination, lower limb proprioception and tactile sensation. 
The cut-off scores suggested may need to be interpreted with 
caution because of the uneven sex ratio and the significant dif-
ference in mean body weight, height and body mass index of 
the 2 groups. The significant gender difference in both muscle 
strength and functional task performance are well documented 
(38, 39). Any future study with larger sample sizes should take 
into account the effects of sex ratios on SWT performance. 
Conclusion
The SWT is an easy-to-administer clinical test for assessing 
sideways walking ability in individuals with stroke. Both SWT 
times and counts demonstrated good to excellent intra-rater, 
inter-rater, and test-retest reliabilities in individuals after 
stroke. Performance of SWT significantly correlated with 
FMA-LE scores, ankle dorsiflexor and plantarflexor strength 
on the affected side, FTSTS times, TUG test times and BBS 
scores. Both SWT times and counts are able to differentiate 
reliably between individuals with stroke and healthy adults. 
Conflicts of interest
No commercial party having a direct financial interest in the 
results of the research supporting this article has or will confer 
a benefit upon the authors or upon any organization with which 
the authors are associated.
J Rehabil Med 48
665Sideways walk test for patients with stroke
REFERENCES
1. Gilchrist L A. Age-related changes in the ability to side-step during 
gait. Clin Biomech 1998; 13: 91–97.
2. Bloomfield J, Polman R, O’Donoghue P. Physical demands of 
different positions in FA Premier League soccer. J Sports Sci Med 
2007; 6: 63–70.
3. Lord S, McPherson K, McNaughton H, Rochester L, Weatherall 
M. Community ambulation after stroke: how important and obtain-
able is it and what measures appear predictive? Arch Phys Med 
Rehabil 2004; 85: 234–239. 
4. Tyson SF, Hanley M, Chillala J, Selley A, Tallis RC. Balance dis-
ability after stroke. Phys Ther 2006; 86: 30–38.
5. Handford M, Srinivasan M. Sideways walking: preferred is slow, 
slow is optimal, and optimal is expensive. Biol Lett 2014; 10: 
20131006. 
6. Danielsson A, Willén C, Sunnerhagen K. Measurement of energy 
cost by the physiological cost index in walking after stroke. Arch 
Phys Med Rehabil 2007; 88: 1298–1303.
7. Obembe A, Olaogun M, Adedoyin R. Gait and balance performance 
of stroke survivors in South-Western Nigeria - a cross-sectional 
study. Pan Afr Med J 2014; 17: 6. 
8. Bryant M, Fernandez A, Hou J, Rintala D, Lai E, Protas E. Inter-
rater reliability of dynamic balance in persons with Parkinson’s dis-
ease (PD). [Cited 2015 May 25]. Available from: https://www.bcm.
edu/neurology/pdf/poster_other_DynamicBalancePD_MDS.pdf.
9. Walter S, Eliasziw M, Donner A. Sample size and optimal designs 
for reliability studies. Statist Med 1998; 17: 101–110. 
10. Feigin V, Lawes C, Bennett D, Anderson C. Stroke epidemiology: 
a review of population-based studies of incidence, prevalence, and 
case-fatality in the late 20th century. Lancet Neurol 2003; 2: 43–53. 
11. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The 
post stroke hemiplegic patient: a method for evaluation of physical 
performance. Scand J Rehabil Med 1975; 7: 12–31.
12. Eng J, Kim C, MacIntyre D. Reliability of lower extremity strength 
measures in persons with chronic stroke. Arch Phys Med Rehabil 
2002; 83: 322–328. 
13.  Conable K, Rosner A. A narrative review of manual muscle test-
ing and implications for muscle testing research. J Chiropr Med 
2011; 10: 157–165.
14. Bohannon RW, Andrews AW. Interrater reliability of hand-held 
dynamometry. Phys Ther 1987; 67: 931–933. 
15. Benett J, Stauber W. Evaluation and treatment of anterior knee 
pain using eccentric exercise. Med Sci Sports 1986; 18: 526–530. 
16. Csuka M, McCarty D. Simple method for measurement of lower 
extremity muscle strength. Am J Med 1985; 78: 77–81. 
17. Guralnik J, Simonsick E, Ferrucci L, Glynn R, Berkman L, 
Blazer, et al. A short physical performance battery assessing lower 
extremity function: association with self-reported disability and 
prediction of mortality and nursing home admission. J Gerontol 
1994; 49: M85–M94. 
18. Mong Y, Teo TW, Ng SS. 5-repetition sit-to-stand test in subjects 
with chronic stroke: reliability and validity. Arch Phys Med Rehabil 
2010; 91: 407–413. 
19. Berg K. Measuring balance in the elderly: preliminary development 
of an instrument. Physiother Can 1989; 41: 304–311. 
20. Berg K, Wood-Dauphinee S, Williams JI. The balance scale reli-
ability assessment with elderly residents and patients with an acute 
stroke. Scand J Rehab Med 1995; 27: 27–36. 
21. Podsiadlo D, Richardson S. The timed “up & go”: a test of basic 
functional mobility for frail elderly persons. J Am Geriatr Soc 
1991; 39: 142–148. 
22. Ng SS, Hui-Chan C. The timed up & go test: its reliability and 
association with lower-limb impairments and locomotor capaci-
ties in people with chronic stroke. Arch Phys Med Rehabil 2005; 
86: 1641–1647. 
23. Powell L, Myers A. The Activities-specific Balance Confidence 
(ABC) Scale. J Gerontol A Biol Sci Med Sci 1995; 50A: M28–M34. 
24. Mak M, Lau A, Law F, Cheung C, Wong I. Validation of the Chinese 
translated Activities-Specific Balance Confidence scale. Arch Phys 
Med Rehabil 2007; 88: 496–503. 
25. Liu T, Ng S, Ng G. Translation and Initial Validation of the Chi-
nese (Cantonese) Version of Community Integration Measure for 
Use in Patients with Chronic Stroke. BioMed Res Int 2014: 1–7. 
26. Portney L, Watkins M. Foundations of clinical research. Upper 
Saddle River: N.J. Pearson/Prentice Hall; 2009.
27. Dancey C, Reidy J. Statistics without maths for psychology: using 
SPSS for Windows. London: Prentice Hall; 2004.
28. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a 
systematic review. Lancet Neurol 2009; 8: 741–754.
29. Gemperline JJ, Allen S, Walk D, Rymer WZ. Characteristics of 
motor unit discharge in subjects with hemiparesis. Muscle Nerve 
1995; 18: 1101–1114.
30. Horstman AM, Beltman MJ, Gerrits KH, Koppe P, Janssen TW, 
Elich P, et al. Intrinsic muscle strength and voluntary activation 
of both lower limb and functional performance after stroke. Clin 
Physiol Funct Imaging 2008; 28: 251–261.
31. Esser P, Dawes H, Collett J, Feltham M, Howells K. Assessment 
of spatio-temporal gait parameters using inertial measurement 
units in neurological populations. Gait Posture 2011; 34: 558–560. 
32. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J 
Neurol Neurosurg Psychiatry 2008; 79: 368–376.
33. Dettmann A, Linder T, Sepic B. Relationships among walking 
performance, postural stability, and functional assessments of the 
hemiplegic patient. Am J Phys Med 1987; 66: 77–90.
34. Courbon A, Calmels P, Roche F, Ramas J, Rimaud D, Fayolle-
Minon I. Relationship between maximal exercise capacity and 
walking capacity in adult hemiplegic stroke patients. Am J Phys 
Med 2006; 85: 436–442. 
35. Nakamura R., Watanabe S, Handa T, Morohashi I. The relationship 
between walking speed and muscle strength for knee extension 
in hemiparetic stroke patients: A follow-up study. Tohoku J Exp 
Med 1988; 154: 111–113. 
36. Nadeau S, Gravel D, Arsenault A, Bourbonnais D. Plantarflexor 
weakness as a limiting factor of gait speed in stroke subjects and the 
compensating role of hip flexors. Clin Biomech 1999; 14: 125–135. 
37. Salbach N, Mayo N, Hanley J, Richards C, Wood-Dauphinee S. 
Psychometric evaluation of the original and Canadian French ver-
sion of the Activities-Specific Balance Confidence scale among 
people with stroke. Arch Phys Med Rehabil 2006; 87: 1597–1604. 
38. Butler A, Menant J, Tiedemann A, Lord S. Age and gender differ-
ences in seven tests of functional mobility. J Neuroeng Rehabil 
2009; 6: 31.
39. Miller A, MacDougall J, Tarnopolsky M, Sale D. Gender dif-
ferences in strength and muscle fiber characteristics. Eur J Appl 
Physiol 1993; 66: 254–262.
J Rehabil Med 48
